SynBiome is a biotechnology company established in June 2022. Founded by returning young scientists and executives from venture capital firms, the company recently completed a funding round of tens of millions of yuan. SynBiome is dedicated to utilizing artificial intelligence and synthetic biology technologies to develop a data-driven microbial engineering platform. Their focus is on researching and developing functional microorganisms and bioactive substances to promote the health of crops, animals, and humans. They provide innovative products and solutions for agriculture, carbon neutrality, and the broader field of health.

Dr. Dai Lei, the co-founder and chief scientist of SynBiome, graduated from the Massachusetts Institute of Technology (MIT) in the United States and has extensive experience in microbial genomics and synthetic biology. Mr. Chen Yin, the co-founder and CEO, graduated from Shanghai University of Finance and Economics and has significant experience in investment and management within the biopharmaceutical and health industries.

Following their recent funding, SynBiome has actively embraced the "upstairs and downstairs innovation and entrepreneurship complex" model pioneered by the Advanced Institute of the Chinese Academy of Sciences (CAS), and they have become a part of the Shenzhen Engineering Biotechnology Industry Innovation Center.

Furthermore, SynBiome leverages the "Shenzhen Major Basic Research Facility for Synthetic Biology" established through collaboration between the Chinese Academy of Sciences and the Shenzhen Municipal Government. This facility provides a high-throughput and automated experimental platform, greatly enhancing the efficiency of industrial transformation for the company's research and innovation.

SynBiome's long-term vision is to create a new life through microorganisms. In addition to advancing their existing pipeline, the company is actively seeking industrial partners and strategic collaborators to promote the application of microbial engineering in various industries such as pet care, cosmetics, skincare, and nutritional health. Their goal is to translate cutting-edge technological innovations into practical applications that benefit society.

Disclaimer: Despite our efforts to maintain accuracy, errors are unavoidable due to our limited expertise. Some information may not be up to date, and we welcome your feedback to make necessary corrections. This document is intended solely for the purpose of providing a business-oriented and written introduction to the field of synthetic biology. It does not constitute any investment advice. We appreciate your understanding.